Crystal structures of the complexes between vancomycin and cell-wall precursor analogs.
Yasushi Nitanai, Takanori Kikuchi, Kouji Kakoi, Shinji Hanamaki, Ikuhide Fujisawa, Katsuyuki Aoki, Yasushi Nitanai, Takanori Kikuchi, Kouji Kakoi, Shinji Hanamaki, Ikuhide Fujisawa, Katsuyuki Aoki
Index: J. Mol. Biol. 385 , 1422-1432, (2009)
Full Text: HTML
Abstract
The crystal structures of three vancomycin complexes with two vancomycin-sensitive cell-wall precursor analogs (diacetyl-Lys-D-Ala-D-Ala and acetyl-D-Ala-D-Ala) and a vancomycin-resistant cell-wall precursor analog (diacetyl-Lys-D-Ala-D-lactate) were determined at atomic resolutions of 1.80 A, 1.07 A, and 0.93 A, respectively. These structures not only reconfirm the "back-to-back" dimerization of vancomycin monomers and the ligand-binding scheme proposed by previous experiments but also show important structural features of strategies for the generation of new glycopeptide antibiotics. These structural features involve a water-mediated antibiotic-ligand interaction and supramolecular structures such as "side-by-side" arranged dimer-to-dimer structures, in addition to ligand-mediated and "face-to-face" arranged dimer-to-dimer structures. In the diacetyl-Lys-D-Ala-D-lactate complex, the interatomic O...O distance between the carbonyl oxygen of the fourth residue of the antibiotic backbone and the ester oxygen of the D-lactate moiety of the ligand is clearly longer than the corresponding N-H...O hydrogen-bonding distance observed in the two other complexes due to electrostatic repulsion. In addition, two neighboring hydrogen bonds are concomitantly lengthened. These observations provide, at least in part, a molecular basis for the reduced antibacterial activity of vancomycin toward vancomycin-resistant bacteria with cell-wall precursors terminating in -D-Ala-D-lactate.
Related Compounds
Related Articles:
2005-01-01
[J. Comb. Chem. 7(1) , 123-9, (2005)]
1982-10-01
[Biochem. J. 207 , 109, (1982)]
1981-12-01
[Eur. J. Biochem. 121(1) , 221-32, (1981)]
2003-08-06
[J. Am. Chem. Soc. 125(31) , 9314-5, (2003)]
Preparation of biologically active ristocetin derivatives: replacements of the 1'-amino group.
1985-09-01
[J. Med. Chem. 28(9) , 1371-5, (1985)]